Dr Mike Roberts Joins Health Analytics Provider C2-Ai as Medical Director

C2-AiUK headquartered healthcare analytics company C2-Ai has appointed a senior clinician as its new medical director international.

Dr Mike Roberts, who has a background in emergency medicine and cardiothoracic surgery, has worked in both the NHS and in New Zealand, where he has held chief medical officer and medical director roles for more than 15 years.

He will now work to help expand how C2-Ai’s products are used by healthcare providers - for both new and existing customers. Hospitals within the NHS and internationally use the company's AI-backed technologies to provide them with intelligence to help enhance patient safety and to improve quality and equity of care.

Since the pandemic C2-Ai's systems have also been used to help surgeons safely and efficiently prioritise patients waiting for hospital treatment, with significant results reported by customers around faster clearing of backlogs, fewer emergency admissions and substantial time released for busy surgeons.

Commenting on his appointment, Dr Roberts said: "I have been extremely enthusiastic about the potential of C2-Ai's technology for many years and I have seen the impact it can achieve first hand as a customer, when it comes to supporting clinical governance. Within minutes of using the company's systems, I was able to see evidence needed to help us improve, evidence that would otherwise have taken years to obtain.

"Healthcare organisations are heavily focussed on improving quality and safety, and C2-Ai's products can play an important role for many hospitals in this ambition, providing leaders with objective, quantitative and reliable insight. Anybody who wants to understand the quality of care, can do and at a granular level.

"Put simply, the company's solutions can help healthcare organisations understand where things are not going well so those services can be improved - which is good for patients and saves money. And it shows where things are going well, so that good practice can be exemplified.

"Whether its surgical areas, maternity services, or a whole range of clinical specialities, hospitals and their executive teams have a responsibility to ensure the governance is in place for safety. C2-Ai's systems support that and can help management teams and clinicians have meaningful conversations to improve performance. I'm proud to be part of a highly respected team that is helping with some of the biggest challenges in healthcare."

Steve Mackenney, CEO at C2-Ai, said: "We work with some of the most forward-thinking hospitals in the world when it comes to using data in effective ways to improve healthcare provision for patients. We are thrilled to expand our team with the appointment of Dr Roberts, who has a wealth of experience to help us to expand this offering to even more hospitals, and to help our existing customers make even more of their investments with us."

About C2-Ai

C2-Ai is a trusted NHS digital approved partner with access to full national datasets and running on the HSCN/N3 network. The company has provided national support for the Keogh Review and to Professor Sir Mike Richards at the CQC, and our systems are locally in use in dozens of NHS trusts and in 11 countries.

C2-Ai provides a unique, AI-backed suite of hospital care quality/efficiency improvement tools (CRAB, Patient List Triage, Observatory & Compass). They are developed from 30 years of research, ten years of development and the world's largest (350m) and geographically broadest patient data set (from 46 countries). In the UK these have a track record for delivering demonstrable improvements in:

  • Reducing avoidable harm and unwarranted variation 
  • Reducing length of stay 
  • Reducing critical care demand 
  • Improving clinical cost effectiveness

Most Popular Now

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

ChatGPT Performs as Well as Doctors for …

The artificial intelligence chatbot ChatGPT performed as well as a trained doctor in suggesting likely diagnoses for patients being assessed in emergency medicine departments, in a pilot study to be...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...

AI may Outperform Most Humans at Creativ…

Large language model (LLM) artificial intelligence (AI) chatbots may be able to outperform the average human at a creative thinking task where the participant devises alternative uses for everyday objects...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

AI and Machine Learning can Successfully…

Artificial intelligence (AI) and machine learning (ML) can effectively detect and diagnose Polycystic Ovary Syndrome (PCOS), which is the most common hormone disorder among women, typically between ages 15 and...